Carl Zeiss Meditec (ETR:AFX) Shares Down 3.1% - What's Next?

Carl Zeiss Meditec AG (ETR:AFX - Get Free Report) shares fell 3.1% on Wednesday . The stock traded as low as €59.95 ($68.91) and last traded at €60.00 ($68.97). 95,859 shares traded hands during trading, an increase of 2% from the average session volume of 94,405 shares. The stock had previously closed at €61.95 ($71.21).

Carl Zeiss Meditec Stock Down 3.1%

The company has a debt-to-equity ratio of 7.41, a current ratio of 2.13 and a quick ratio of 2.47. The firm's 50-day simple moving average is €59.09 and its two-hundred day simple moving average is €56.35. The company has a market capitalization of $5.59 billion, a price-to-earnings ratio of 32.07, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.